Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Revenue CAGR (5Y)
-49.6%
Margin Trend
improving
Free Cash Flow
($0.0B)
Profitability
Now unprofitable
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 3↑5528.1% | 1↓83.5% | 3↑530.6% | 0↓98.2% |
| Gross Profit | -1 | 3↑347.7% | 1↓83.5% | 3↑512.6% | -0↓104.5% |
| Operating Income | -10 | -2↑84.3% | -2↓39.2% | -3↓37.8% | -17↓444.8% |
| Net Income | -11 | -1↑88.4% | -3↓112.1% | 5↑296.4% | -11↓311.4% |
| EBITDA | -9 | -1↑85.9% | -3↓112.1% | 6↑327.1% | -10↓277.2% |
| EPS Diluted | -10.14 | -8.05↑20.6% | -2.49↑69.1% | 0.63↑125.3% | -1.51↓339.7% |
1 / 2
Values in millions except EPS · Ratios shown as percentages